Sagespring Wealth Partners LLC Purchases 1,018 Shares of Danaher Corporation $DHR

Sagespring Wealth Partners LLC increased its holdings in Danaher Corporation (NYSE:DHR) by 22.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,553 shares of the conglomerate’s stock after purchasing an additional 1,018 shares during the period. Sagespring Wealth Partners LLC’s holdings in Danaher were worth $1,097,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. MGO One Seven LLC increased its holdings in shares of Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after buying an additional 20,813 shares during the last quarter. Chicago Capital LLC increased its stake in Danaher by 11.6% during the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after acquiring an additional 1,391 shares during the last quarter. UniSuper Management Pty Ltd increased its stake in Danaher by 1.6% during the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after acquiring an additional 2,667 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in Danaher during the first quarter worth approximately $539,000. Finally, Horizon Financial Services LLC increased its stake in Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after acquiring an additional 8,160 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on DHR. Weiss Ratings reissued a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Redburn Partners set a $220.00 target price on Danaher in a research note on Wednesday, October 8th. Finally, Rothschild & Co Redburn reaffirmed a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Seventeen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $244.60.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Up 0.1%

Shares of NYSE:DHR opened at $206.32 on Thursday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $201.18 and its 200 day moving average is $197.19. The stock has a market cap of $147.73 billion, a P/E ratio of 43.90, a price-to-earnings-growth ratio of 2.94 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the company earned $1.72 EPS. The business’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.